Lhasa Limited shared knowledge shared progress

Dr Krista Dobo

5 Krista Dobo Lhasa Limited Board Member





Current position on board of trustees:

Director/Trustee (2017 - Present)

Affiliation/job title/status:

Pfizer Worldwide Research and Development Senior Director


Career history, education and experience:

Krista is currently the Senior Director of the Genetic Toxicology Department at Pfizer Worldwide Research and Development in Groton, CT.  

She holds a B.S. in Biology from Indiana University of Pennsylvania, and received her Ph. D. in Environmental Toxicology from the University of California, Riverside. During her graduate years she applied various in vitro genotoxicity assays to evaluate mechanisms of clastogenicity and mutagenicity.

She was a post-doctoral fellow for 1 year in the Genetic Toxicology Department at Bristol-Myers Squibb. She then joined the Genetic Toxicology group at Pfizer in 1997.

Currently, in addition to her role leading the Genetic Toxicology group, Krista provides subject matter expertise for impurity related issues for projects across all stages of drug development as well as for marketed products. She has contributed her expertise to numerous cross-industry initiatives, such as active participation in PhRMA LDKIT efforts to revise the ICH Genetic Toxicology Testing Guidance (ICHS2R) and develop the ICH M7 Guideline and Addendum.

Krista has served two terms as a member of the Genetic Toxicology Association (GTA) Board of Directors and also acted as Chair of the GTA. She is also a former Councilor of the Environmental Mutagenesis and Genomics Society (EMGS), and served as Co-Chair of the EMGS Applied Genetic Toxicology special interest group.  

© 2023 Lhasa Limited | Registered office: Granary Wharf House, 2 Canal Wharf, Leeds, LS11 5PS, UK Tel: +44 (0)113 394 6020
VAT number 396 8737 77 | Lhasa Limited is registered as a charity (290866)| Company Registration Number 01765239 (England and Wales).